MISSING HLA C GROUP 1 LIGAND IN PATIENTS WITH AML AND MDS IS ASSOCIATED WITH REDUCED RISK OF RELAPSE AND IMPROVED SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH FLUDARABINE AND TREOSULFAN REDUCED TOXICITY CONDITIONING
Abstract
Publication Date:
2014
Iris type:
1.5 Abstract in rivista
List of contributors:
Shimoni, A; Bernardi, M; Yerushalmi, R; Peccatori, J; Shem-Tov, N; Lo Russo, A; Volchek, Y; Vago, L; Bonini, C; Stanghellini, Mtl; Nagler, A; Ciceri, F
Published in: